封面
市场调查报告书
商品编码
1890917

载玻片染色市场:依产品、技术、应用、最终用户、连接方式、地区划分

Slide Staining Market, By Product, By Technique, By Application, By End User, By Connectivity, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2025 年,玻片染色市场价值为 49.4 亿美元,到 2032 年将达到 78.3 亿美元,2025 年至 2032 年的复合年增长率为 6.8%。

报告内容 报告详情
基准年: 2024 2025年市场规模: 49.4亿美元
历史数据时期: 2020年至2024年 预测期: 2025年至2032年
预测期(2025-2032年)复合年增长率: 6.80% 2032 年的预测值: 78.3亿美元

全球玻片染色市场是临床实验室和病理学行业的重要组成部分,涵盖了生物标本显微镜检查所需的各种化学试剂、自动化系统和耗材。玻片染色是临床诊断、研究和教育机构的基础技术,使医疗专业人员和研究人员能够观察细胞结构、识别病理状况并进行全面的组织分析。

该市场涵盖多种染色技术,例如苏木精-伊红 (H&E) 染色、免疫组织化学 (IHC) 染色、特殊染色和萤光染色技术,每种技术都服务于特定的诊断和研究目的。慢性病发病率的上升、对精确诊断程序的需求不断增长以及对个人化医疗的日益重视,正在推动该市场的显着增长。

此外,自动化染色系统的技术进步、新型染色试剂的研发以及数位病理解决方案的整合正在重塑市场格局。该市场涵盖医院、诊断检查室、学术研究机构和製药公司等各类终端用户,所有这些用户共同推动了全球医疗保健系统对可靠且高效的玻片染色解决方案日益增长的需求。

市场动态

全球切片染色市场受到几个关键因素的驱动,这些因素正在推动其在各种医疗保健环境中扩张,主要是由于全球癌症发病率的增加,这需要透过先进的染色技术(特别是免疫组织化学和特殊染色)进行准确的组织病理学诊断,以进行肿瘤表征和治疗计划。

老年人口的不断增长,以及由此带来的各种慢性疾病的高风险,进一步增加了对需要玻片染色的诊断程序的需求。自动化染色系统的技术进步提高了检查室效率,减少了人为误差,并使结果标准化,从而促进了医疗机构优化工作流程的采用。医疗基础设施投资的增加,尤其是在新兴经济体,扩大了市场准入,而人们对疾病早期检测意识提升则推动了预防医学的发展。

然而,该市场也面临诸多限制因素。自动化染色设备需要大量的初始投资,这对预算有限的小规模检查室和医疗机构构成了挑战。此外,染色试剂和设备的核准流程涉及复杂的法规结构,这也阻碍了新进入者和新产品的上市。

熟练的实验室技术人员和病理学家短缺,尤其是在发展中地区,限制了市场成长潜力。此外,严格的品管要求和标准化通讯协定增加了製造商和终端用户的营运成本。儘管存在这些挑战,将人工智慧 (AI) 和数位病理解决方案与传统染色技术相结合,为提高诊断准确性和远端会诊能力提供了重要机会。个人化医疗和伴随诊断领域应用的不断拓展提供了盈利的成长路径,而生物技术和製药领域日益活跃的研究活动也推动了对专用染色解决方案的需求。

本次调查的主要特点

  • 本报告对全球玻片染色市场进行了详细分析,以 2024 年为基准年,给出了预测期(2025-2032 年)的市场规模(十亿美元)和復合年增长率(%)。
  • 它还重点介绍了各个细分市场的潜在商机,并说明了该市场具有吸引力的投资提案矩阵。
  • 该研究还提供了有关市场驱动因素、阻碍因素、机会、新产品发布或核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
  • 本报告根据以下参数对全球玻片染色市场的主要企业进行了分析:公司概况、产品系列、主要亮点、财务绩效和策略。
  • 本报告的研究结果将使负责人和企业经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 这份全球玻片染色市场报告的目标受众是该行业的各类相关人员,包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
  • 相关人员可以透过各种用于分析全球载玻片染色市场的策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场范围

  • 报告概述
    • 市场定义和范围
  • 执行摘要

第三章 市场动态、监管与趋势分析

  • 市场动态
  • 司机
  • 抑制因素
  • 机会
  • 影响分析
  • 重大进展
  • 法规环境
  • 产品上市及核准
  • PEST分析
  • 波特分析
  • 併购趋势
  • 产业趋势

4. 2020-2032年全球玻片染色市场(依产品划分)

  • 试剂和试剂盒
  • 装置
  • 其他耗材和配件

5. 2020-2032年全球玻片染色市场依自动化程度划分

  • 全自动
  • 半自动
  • 手动/桌面型

6. 2020-2032年全球玻片染色市场(依技术划分)

  • 组织学:H&E染色,特殊染色
  • 免疫组织化学(IHC)
  • 原位杂合反应(ISH/FISH/CISH)
  • 细胞学染色(例如,改良的巴氏染色法)
  • 微生物染色(例如,革兰氏染色、抗酸染色、芽孢染色)
  • 血液学染色(例如,Wright-Giemsa染色)

7. 2020-2032年全球玻片染色市场(依应用领域划分)

  • 疾病诊断
  • 生物标记发现/伴随诊断
  • 药物发现与临床前试验
  • 学术和转化研究
  • 品管和能力验证

8. 2020-2032年全球玻片染色市场(依最终用户划分)

  • 医院和参考病理检查室
  • 製药和生物技术公司
  • 合约研究组织(CRO)
  • 独立诊断检查室
  • 学术和研究机构
  • 其他(政府、公共卫生机构等)

9. 全球玻片染色市场:依性别划分,2020-2032 年

  • 独立系统
  • LIS/LIMS 整合系统
  • 远端/物联网监控

第十章 全球玻片染色市场(依地区划分),2020-2032年

  • 北美洲
    • 美国
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲国家
  • 欧洲
    • 德国
    • 英国
    • 西班牙
    • 法国
    • 义大利
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • ASEAN
    • 亚太其他地区
  • 中东
    • 海湾合作委员会国家
    • 以色列
    • 其他中东国家
  • 非洲
    • 南非
    • 北非
    • 中非

第十一章 竞争格局

  • Roche Diagnostics(Ventana Medical Systems)
  • Agilent Technologies(Dako)
  • Danaher(Leica Biosystems)
  • Thermo Fisher Scientific(Epredia)
  • Sakura Finetek
  • ELITechGroup
  • BioGenex
  • Biocare Medical
  • Merck KGaA(MilliporeSigma)
  • Abcam plc
  • Bio-Rad Laboratories
  • Diapath SpA
  • SLEE medical GmbH
  • MEDITE Medical GmbH
  • CellPath Ltd

第十二章 分析师建议

  • 机会
  • 分析师观点
  • Coherent Opportunity Map

第十三章 参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI8843

Slide Staining Market is estimated to be valued at USD 4.94 Bn in 2025 and is expected to reach USD 7.83 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4.94 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.80% 2032 Value Projection: USD 7.83 Bn

The global slide staining market represents a critical segment within the broader laboratory diagnostics and pathology industry, encompassing various chemical reagents, automated systems, and consumables essential for microscopic examination of biological specimens. Slide staining serves as a fundamental technique in clinical diagnostics, research applications, and educational institutions, enabling healthcare professionals and researchers to visualize cellular structures, identify pathological conditions, and conduct comprehensive tissue analysis.

This market includes diverse staining methodologies such as hematoxylin and eosin (H&E), immunohistochemistry (IHC), special stains, and fluorescent staining techniques, each serving specific diagnostic and research purposes. The increasing prevalence of chronic diseases, rising demand for accurate diagnostic procedures, and growing emphasis on personalized medicine are driving substantial growth in this market.

Additionally, technological advancements in automated staining systems, development of novel staining reagents, and integration of digital pathology solutions are reshaping the landscape. The market encompasses various end users including hospitals, diagnostic laboratories, academic research institutions, and pharmaceutical companies, all contributing to the expanding demand for reliable and efficient slide staining solutions across global healthcare systems.

Market Dynamics

The global slide staining market is propelled by several key drivers that collectively fuel its expansion across diverse healthcare settings. The primary driver stems from the escalating incidence of cancer worldwide, necessitating accurate histopathological diagnosis through advanced staining techniques, particularly immunohistochemistry and special stains for tumor characterization and treatment planning.

Rising geriatric population susceptible to various chronic diseases further amplifies demand for diagnostic procedures requiring slide staining. Technological advancements in automated staining systems enhance laboratory efficiency, reduce human error, and standardize results, driving adoption among healthcare facilities seeking improved workflow optimization. Growing investments in healthcare infrastructure, particularly in emerging economies, expand market accessibility while increasing awareness about early disease detection promotes preventive healthcare practices.

However, the market faces significant restraints including high initial capital investment required for automated staining equipment, which poses challenges for smaller laboratories and healthcare facilities with limited budgets. Complex regulatory frameworks governing staining reagents and equipment approval processes create barriers for new market entrants and product launches.

Shortage of skilled laboratory technicians and pathologists, particularly in developing regions, limits market growth potential. Additionally, stringent quality control requirements and standardization protocols increase operational costs for manufacturers and end-users. Despite these challenges, substantial opportunities emerge from the integration of artificial intelligence and digital pathology solutions with traditional staining techniques, enabling enhanced diagnostic accuracy and remote consultation capabilities. Expanding applications in personalized medicine and companion diagnostics present lucrative growth avenues, while increasing research activities in biotechnology and pharmaceutical sectors drive demand for specialized staining solutions.

Key Features of the Study

  • This report provides in-depth analysis of the global slide staining market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global slide staining market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Roche Diagnostics (Ventana Medical Systems), Agilent Technologies (Dako), Danaher (Leica Biosystems), Thermo Fisher Scientific (Epredia), Sakura Finetek, ELITechGroup, BioGenex, Biocare Medical, Merck KGaA (MilliporeSigma), Abcam plc, Bio-Rad Laboratories, Diapath S.p.A., SLEE medical GmbH, MEDITE Medical GmbH, and CellPath Ltd
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global slide staining market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global slide staining market

Market Segmentation

  • Product Insights (Revenue, USD Bn, 2020 - 2032)
    • Reagents and Kits
    • Antibodies (Primary, Secondary)
    • Dyes and Stains (Hematoxylin, Eosin, Romanowsky, Papanicolaou, Special Stains)
    • Blocking Sera and Buffers
    • Mounting Media
    • Fixatives
    • Instruments
    • Automated Slide Stainers
    • Manual Staining Systems
    • Slide Warmers and Dryers
    • Cover slippers
    • Other Consumables and Accessories
  • Automation Level Insights (Revenue, USD Bn, 2020 - 2032)
    • Fully automated
    • Semi-automated
    • Manual/benchtop
  • Technique Insights (Revenue, USD Bn, 2020 - 2032)
    • Histology: HandE, special stains
    • Immunohistochemistry (IHC)
    • In-situ hybridization (ISH/FISH/CISH)
    • Cytology staining (e.g., Pap variants)
    • Microbiology staining (e.g., Gram, AFB, spore)
    • Hematology staining (e.g., Wright-Giemsa)
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Disease diagnosis
    • Biomarker detection/companion diagnostics
    • Drug discovery and preclinical studies
    • Academic and translational research
    • Quality control and proficiency testing
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospital and reference pathology labs
    • Pharmaceutical and Biotechnology Companies
    • Contract Research Organizations (CROs)
    • Independent diagnostic labs
    • Academic and research institute
    • Others (Government and public health labs, etc.)
  • Connectivity Insights (Revenue, USD Bn, 2020 - 2032)
    • Standalone systems
    • LIS/LIMS-integrated systems
    • Remote/IoT-enabled monitoring
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Roche Diagnostics (Ventana Medical Systems)
    • Agilent Technologies (Dako)
    • Danaher (Leica Biosystems)
    • Thermo Fisher Scientific (Epredia)
    • Sakura Finetek
    • ELITechGroup
    • BioGenex
    • Biocare Medical
    • Merck KGaA (MilliporeSigma)
    • Abcam plc
    • Bio-Rad Laboratories
    • Diapath S.p.A.
    • SLEE medical GmbH
    • MEDITE Medical GmbH
    • CellPath Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Slide Staining Market, By Product
    • Global Slide Staining Market, By Automation Level
    • Global Slide Staining Market, By Technique
    • Global Slide Staining Market, By Application
    • Global Slide Staining Market, By End User
    • Global Slide Staining Market, By Connectivity
    • Global Slide Staining Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Slide Staining Market, By Product, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Reagents and Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Antibodies (Primary, Secondary)
      • Dyes and Stains (Hematoxylin, Eosin, Romanowsky, Papanicolaou, Special Stains)
      • Blocking Sera and Buffers
      • Mounting Media
      • Fixatives
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Automated Slide Stainers
      • Manual Staining Systems
      • Slide Warmers and Dryers
      • Cover slippers
  • Other Consumables and Accessories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Slide Staining Market, By Automation Level, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Fully automated
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Semi-automated
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Manual/benchtop
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Slide Staining Market, By Technique, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Histology: HandE, special stains
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Immunohistochemistry (IHC)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • In-situ hybridization (ISH/FISH/CISH)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cytology staining (e.g., Pap variants)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Microbiology staining (e.g., Gram, AFB, spore)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Hematology staining (e.g., Wright-Giemsa)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Slide Staining Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Disease diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biomarker detection/companion diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Drug discovery and preclinical studies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Academic and translational research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Quality control and proficiency testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Slide Staining Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital and reference pathology labs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Independent diagnostic labs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Academic and research institute
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Government and public health labs, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Slide Staining Market, By Connectivity, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Standalone systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • LIS/LIMS-integrated systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Remote/IoT-enabled monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Slide Staining Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Connectivity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Connectivity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Connectivity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Connectivity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Connectivity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Connectivity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • Roche Diagnostics (Ventana Medical Systems)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies (Dako)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher (Leica Biosystems)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific (Epredia)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sakura Finetek
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ELITechGroup
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BioGenex
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Biocare Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA (MilliporeSigma)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abcam plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Diapath S.p.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • SLEE medical GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • MEDITE Medical GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CellPath Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About us